β-amyloid induces a dying-back process and remote trans-synaptic alterations in a microfluidic-based reconstructed neuronal network
暂无分享,去创建一个
Jean-Louis Viovy | Jean-Michel Peyrin | J. Viovy | E. Jacotot | M. Belle | Maéva Vignes | Bérangère Deleglise | Bernard Brugg | Morgane Belle | Bérangère Deleglise | Sébastien Magnifico | E. Duplus | P. Vaur | Vanessa Soubeyre | J. Peyrin | B. Brugg | Etienne Jacotot | Sebastien Magnifico | Eric Duplus | Pauline Vaur | Vanessa Soubeyre | Maeva Vignes
[1] Noo Li Jeon,et al. β‐Amyloid is transmitted via neuronal connections along axonal membranes , 2014, Annals of neurology.
[2] Jean-Louis Viovy,et al. Synapto-Protective Drugs Evaluation in Reconstructed Neuronal Network , 2013, PloS one.
[3] Jean-Louis Viovy,et al. Axon diodes for the reconstruction of oriented neuronal networks in microfluidic chambers. , 2011, Lab on a chip.
[4] F. Schmitt,et al. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment , 2007, Neurology.
[5] Nick C Fox,et al. Molecular nexopathies: a new paradigm of neurodegenerative disease , 2013, Trends in Neurosciences.
[6] L. Mucke,et al. Epilepsy and cognitive impairments in Alzheimer disease. , 2009, Archives of neurology.
[7] Jean-Louis Viovy,et al. Wallerian-Like Degeneration of Central Neurons After Synchronized and Geometrically Registered Mass Axotomy in a Three-Compartmental Microfluidic Chip , 2010, Neurotoxicity Research.
[8] J. Viovy,et al. NAD+ acts on mitochondrial SirT3 to prevent axonal caspase activation and axonal degeneration , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] F. García-Sierra,et al. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.
[10] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[11] R. Terry. Cell death or synaptic loss in Alzheimer disease. , 2000, Journal of neuropathology and experimental neurology.
[12] L. Mucke,et al. Amyloid-β–induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks , 2010, Nature Neuroscience.
[13] C. Cotman,et al. A microfluidic culture platform for CNS axonal injury, regeneration and transport , 2005, Nature Methods.
[14] Mathias Jucker,et al. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases , 2013, Nature.
[15] R. Adalbert,et al. Review: Axon pathology in age‐related neurodegenerative disorders , 2013, Neuropathology and applied neurobiology.
[16] I. Grundke‐Iqbal,et al. Dysregulation of tau phosphorylation in mouse brain during excitotoxic damage. , 2009, Journal of Alzheimer's disease : JAD.
[17] M. Gillette,et al. New perspectives on neuronal development via microfluidic environments , 2012, Trends in Neurosciences.
[18] G. Krafft,et al. In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis* , 2003, The Journal of Biological Chemistry.
[19] Anatol C. Kreitzer,et al. Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.
[20] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[21] S. Kar,et al. β-Amyloid-related peptides potentiate K+-evoked glutamate release from adult rat hippocampal slices , 2010, Neurobiology of Aging.
[22] F. Polleux,et al. The CAMKK2-AMPK Kinase Pathway Mediates the Synaptotoxic Effects of Aβ Oligomers through Tau Phosphorylation , 2013, Neuron.